Stocks
Agios Pharmaceuticals (AGIO) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 124.2% | -21.1% | -43.4% | 43.7% | -34.6% | -38.1% | ||
| Changes by years, y/y, % | +206pp | -145pp | -22pp | +87pp | -78pp | -15.8% | |||
Agios Pharmaceuticals. ROE, %
Agios Pharmaceuticals. ROE, changes, pp
Agios Pharmaceuticals (AGIO) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 45.4% | 47.5% | -31.2% | -34.6% | -38.1% | -38.1% | |
| Changes by years, y/y, % | +93pp | +103pp | -73pp | -78pp | -84pp | |||
| Changes by quarters, q/q, % | +2pp | +2pp | -79pp | -3pp | -4pp | |||
